Sun Pharma To Make Eli Lilly's Covid Medicine In India; Shares Gain

Shares of the country's leading drug maker Sun Pharmaceutical Industries rose as much as 3.51 per cent to hit an intraday high of Rs 703.40 on the BSE after it signed an agreement with Eli Lilly to manufacture its drug, baricitinib in India. "Sun Pharma today announced that it has entered into a royalty-free, non-exclusive voluntary licensing agreement with Eli Lilly and Company for expanding access to Lilly's drug, baricitinib in In...